Page 9 of 19 · 436 questions tagged vendor-vetting.
For reference: method section · TFC. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably comfortable…
Concretely: 98.4% · tirzepatide · BCH. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in view and I would like the…
The particulars: PeptideMeter · Qingdao Saber Technology. I want to understand what this actually establishes, as opposed to what it is being used to imply. My…
Stated plainly: FGP · a GLP-1 receptor agonist. This is not behaving the way I expected and I want to understand the discrepancy before I act on it. I have…
This is my second independent submission on material from the same supplier. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware…
This is my second independent submission on material from the same supplier. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware…
The specifics, since they change the answer: date of analysis · TFC. I want to understand what this actually establishes, as opposed to what it is being used to…
The particulars: tirzepatide · list of related substances. I want to understand what this actually establishes, as opposed to what it is being used to imply. My…
What I have: a GLP-1 receptor agonist · lot-specific certificate. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not…
For reference: PeptideMeter · Tianjin Finder Chemical. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern…
What I am working with: dulaglutide · sampling plan. I have read the primary source rather than the summary, which has left me with more questions. I understand the…
The specifics, since they change the answer: method section · QST. I have the document in front of me and I can read the numbers. What I cannot do is interpret them.…
Details up front: SWB · Shanghai ERP Biotechnology. I have used one of these for a while and I am considering switching, which requires a reason. What I care about is…
Numbers first: 96.4% · orforglipron · QYB. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum viable…
Numbers first: SWB · Flourishglobal Peptide Biotech. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a…
The particulars: method section · HJ. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably comfortable…
Stated plainly: 98.2% · cagrilintide · QST. I would like to set this up properly once, rather than adjust it repeatedly. My budget is real but not tight, and my…
What I am working with: lot-specific certificate · KP. I have read the primary source rather than the summary, which has left me with more questions. I understand the…
The particulars: MKM · ecnoglutide. I would like to know whether this claim survives contact with evidence. If the answer is "nobody has tested that", I would like…
Setup, so nobody has to ask: 99.1% · mazdutide · QST. I would like to set this up properly once, rather than adjust it repeatedly. My budget is real but not tight,…
Details up front: Janoshik · Shanghai ERP Biotechnology. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at…
This is a first order from this supplier, so I have no track record to reason from. Everything I have found on this is either a forum aside or a product page, neither…
The particulars: 97.1% · ecnoglutide · JEEP. I am at the decision point and I would rather think it through than improvise. I would rather spend money on measurement…
This is my second independent submission on material from the same supplier. I would like to define my thresholds before I have a result, for obvious reasons. I want…